Merit Medical Systems, Inc. $MMSI Stock Bought by Boston Trust Walden Corp

Boston Trust Walden Corp raised its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 12.4% in the third quarter, Holdings Channel reports. The fund owned 531,396 shares of the medical instruments supplier’s stock after buying an additional 58,540 shares during the period. Boston Trust Walden Corp’s holdings in Merit Medical Systems were worth $45,822,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of MMSI. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Merit Medical Systems by 11.7% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 173,854 shares of the medical instruments supplier’s stock worth $12,055,000 after buying an additional 18,276 shares during the last quarter. Jupiter Topco LLC purchased a new stake in Merit Medical Systems in the 2nd quarter valued at $1,908,000. Trillium Asset Management LLC acquired a new stake in shares of Merit Medical Systems in the 2nd quarter worth $6,105,000. Irenic Capital Management LP acquired a new stake in shares of Merit Medical Systems in the 2nd quarter worth $37,623,000. Finally, Quantinno Capital Management LP increased its stake in shares of Merit Medical Systems by 200.3% in the 1st quarter. Quantinno Capital Management LP now owns 17,612 shares of the medical instruments supplier’s stock worth $1,214,000 after acquiring an additional 11,747 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Trading Up 7.7%

NASDAQ MMSI opened at $90.63 on Thursday. Merit Medical Systems, Inc. has a 52 week low of $59.74 and a 52 week high of $94.85. The firm has a 50 day moving average of $88.34 and a two-hundred day moving average of $77.22. The company has a quick ratio of 3.05, a current ratio of 4.52 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $5.43 billion, a PE ratio of 34.07, a price-to-earnings-growth ratio of 2.06 and a beta of 0.56.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, beating the consensus estimate of $1.04 by $0.08. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. The company had revenue of $416.24 million for the quarter, compared to analyst estimates of $410.56 million. During the same period in the prior year, the firm posted $0.92 earnings per share. The firm’s revenue was up 8.4% on a year-over-year basis. As a group, research analysts expect that Merit Medical Systems, Inc. will post 3.84 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on MMSI shares. Needham & Company LLC raised their price objective on shares of Merit Medical Systems from $101.00 to $106.00 and gave the stock a “buy” rating in a research report on Friday, October 30th. Zacks Research lowered shares of Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Monday, October 19th. Freedom Capital initiated coverage on shares of Merit Medical Systems in a report on Tuesday, October 27th. They issued a “hold” rating on the stock. JPMorgan Chase & Co. increased their price target on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a research note on Friday, October 30th. Finally, Raymond James Financial restated an “outperform” rating and set a $100.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Merit Medical Systems presently has an average rating of “Moderate Buy” and a consensus price target of $105.55.

About Merit Medical Systems

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.